Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Pain Medicine Topic Center

News
FDA Approves Evoke Spinal Cord Stimulation System for Chronic Intractable Pain
03/25/2022
Jolynn Tumolo
The US Food & Drug Administration recently approved the Evoke® Spinal Cord Stimulation (SCS) System for the treatment of chronic intractable pain of the trunk and/or limbs.
The US Food & Drug Administration recently approved the Evoke® Spinal Cord Stimulation (SCS) System for the treatment of chronic intractable pain of the trunk and/or limbs.
The US Food & Drug...
03/25/2022
Neurology
Quiz
Patients With Fibromyalgia Reported More Pain Relief With Which Treatment?
02/01/2022
True or False: Patients with fibromyalgia reported larger improvements in pain relief with conventional pain medicines compared to cannabidiol (CBD) products.
True or False: Patients with fibromyalgia reported larger improvements in pain relief with conventional pain medicines compared to cannabidiol (CBD) products.
True or False: Patients with...
02/01/2022
Neurology
News
Patients With Fibromyalgia Substitute CBD Products for Conventional Pain Medication
06/29/2021
Patients with fibromyalgia are substituting conventional pain medicines such as opioids with cannabidiol (CBD) products, despite a lack of evidence on the effectiveness of CBD as a pain reliever for the illness.
Patients with fibromyalgia are substituting conventional pain medicines such as opioids with cannabidiol (CBD) products, despite a lack of evidence on the effectiveness of CBD as a pain reliever for the illness.
Patients with fibromyalgia are...
06/29/2021
Neurology
News
HHS Announces Guideline to Expand Access to Opioid Use Disorder Treatment
01/19/2021
The guideline, which is still under review, will do away with a certain waiver requirement to allow more physicians to prescribe medication-assisted treatment for opioid use disorder.
The guideline, which is still under review, will do away with a certain waiver requirement to allow more physicians to prescribe medication-assisted treatment for opioid use disorder.
The guideline, which is still...
01/19/2021
Neurology
What is the Prognostic Screening Test of Choice Prior to Lumbar Facet Radiofrequency Ablation?
Quiz
What is the Prognostic Screening Test of Choice Prior to Lumbar Facet Radiofrequency Ablation?
10/30/2020
Take the quiz now to test your knowledge!
Take the quiz now to test your knowledge!
Take the quiz now to test your...
10/30/2020
Neurology
News
Opioid Abuse Disease Burden: Neurological Comorbidities Are an “Underappreciated Contributor”
10/06/2020
In a new study presented at the ANA's 145th Annual Meeting, researchers investigated the prevalence of neurological comorbidities among hospitalized patients with opioid abuse.
In a new study presented at the ANA's 145th Annual Meeting, researchers investigated the prevalence of neurological comorbidities among hospitalized patients with opioid abuse.
In a new study presented at the...
10/06/2020
Neurology
News
Chronic Low Back Pain: Predictors of Response to Yoga, Physical Therapy Identified
07/15/2020
New findings published in the journal Pain Medicine have shed light on predictors of treatment response to yoga, physical therapy, or a self-care book among patients with chronic low back pain.
New findings published in the journal Pain Medicine have shed light on predictors of treatment response to yoga, physical therapy, or a self-care book among patients with chronic low back pain.
New findings published in the...
07/15/2020
Neurology
News
FDA Approves Neurostimulation System for Chronic Low Back Pain
06/23/2020
The FDA has approved an implantable neurostimulation system designed for the treatment of intractable chronic low back pain associated with multifidus muscle dysfunction.
The FDA has approved an implantable neurostimulation system designed for the treatment of intractable chronic low back pain associated with multifidus muscle dysfunction.
The FDA has approved an...
06/23/2020
Neurology
Parsonage-Turner Syndrome
Parsonage-Turner Syndrome
04/24/2020
The presentation of Parsonage-Turner syndrome is characterized by a sudden onset of unilateral shoulder pain and flaccid paralysis of the shoulder and parascapular muscles within a few days.
The presentation of Parsonage-Turner syndrome is characterized by a sudden onset of unilateral shoulder pain and flaccid paralysis of the shoulder and parascapular muscles within a few days.
The presentation of...
04/24/2020
Neurology
Neuropathic Pain: Case Report and Considerations in Children and Adolescents
10/09/2019
Current evidence shows that the incidence of and prognosis of neuropathic pain differ in children compared with adults.
Current evidence shows that the incidence of and prognosis of neuropathic pain differ in children compared with adults.
Current evidence shows that the...
10/09/2019
Neurology

Advertisement

Advertisement

News

brain waves
News
Targeted Brain Stimulation Could Benefit Chronic Pain Treatment
01/22/2024
Jolynn Tumolo
Less than 2 minutes of transcranial magnetic stimulation that targeted the left dorsolateral prefrontal cortex (DLPFC) of the brain boosted hypnotizability for about an hour in low-to-medium hypnotizable people living with fibromyalgia.
Less than 2 minutes of transcranial magnetic stimulation that targeted the left dorsolateral prefrontal cortex (DLPFC) of the brain boosted hypnotizability for about an hour in low-to-medium hypnotizable people living with fibromyalgia.
Less than 2 minutes of...
01/22/2024
Neurology
A person completes a puzzle of a profile of a head, with a piece missing from where the brain is located.
News
ME/CFS and Fibromyalgia May Fall Along Same Illness Spectrum, CSF Analysis Suggests
01/16/2024
Jolynn Tumolo
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia do not appear to be distinct conditions, according to an analysis of cerebrospinal fluid (CSF) proteomes
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia do not appear to be distinct conditions, according to an analysis of cerebrospinal fluid (CSF) proteomes
Myalgic...
01/16/2024
Neurology
A woman holds her forehead in pain with a migraine while talking to a doctor
News
Novel Migraine Pathways Could Guide Drug Development
11/28/2023
Jolynn Tumolo
An analysis of genetic data from more than 1.3 million people has revealed new biological pathways associated with migraine that could potentially be targeted for drug development.
An analysis of genetic data from more than 1.3 million people has revealed new biological pathways associated with migraine that could potentially be targeted for drug development.
An analysis of genetic data from...
11/28/2023
Neurology
Neurologist with patient
News
In Patients With Fibromyalgia, CBT Reduces Pain Catastrophizing, Alters Brain Connectivity
09/25/2023
Jolynn Tumolo
Cognitive behavioral therapy (CBT) was superior to a matched education treatment for decreasing pain-related catastrophizing and improving function in patients with fibromyalgia.
Cognitive behavioral therapy (CBT) was superior to a matched education treatment for decreasing pain-related catastrophizing and improving function in patients with fibromyalgia.
Cognitive behavioral therapy...
09/25/2023
Neurology
A middle-aged man wearing glasses sits holding his temple with migraine pain
News
As-Needed Intranasal Ketamine Relieves Refractory Migraine Pain in Some Patients
06/05/2023
Jolynn Tumolo
Nearly half of patients with refractory chronic migraine interviewed about their use of intranasal ketamine considered the treatment “very effective,” and more than two-thirds said it improved their quality of life.
Nearly half of patients with refractory chronic migraine interviewed about their use of intranasal ketamine considered the treatment “very effective,” and more than two-thirds said it improved their quality of life.
Nearly half of patients with...
06/05/2023
Neurology
3D rendering of an active nerve cell
News
Spontaneous Chronic Pain Predicted by Signatures in the Orbitofrontal Cortex, Small Study Finds
05/31/2023
Jolynn Tumolo
Using machine learning methods, researchers have identified biomarkers of chronic pain in a specific area of the brain in 4 patients. They published their findings in Nature Neuroscience.
Using machine learning methods, researchers have identified biomarkers of chronic pain in a specific area of the brain in 4 patients. They published their findings in Nature Neuroscience.
Using machine learning methods,...
05/31/2023
Neurology
News
Online Pain Programs Reduce Anxiety, Depressive Symptoms in People With Chronic Pain
12/26/2022
Jolynn Tumolo
An online pain management program reduced anxiety and depressive symptoms in adults with chronic pain, according to study results published online ahead of print in Pain Medicine.
An online pain management program reduced anxiety and depressive symptoms in adults with chronic pain, according to study results published online ahead of print in Pain Medicine.
An online pain management...
12/26/2022
Psych Congress Network
News
Vestibular Symptoms, Especially Dizziness, Linked With Migraine
08/09/2022
Jolynn Tumolo
Dizziness and vertigo were significantly related to migraine headaches in a study of nurses at a tertiary hospital in Beijing, China. Researchers published their findings online in Frontiers in Neuroscience.
Dizziness and vertigo were significantly related to migraine headaches in a study of nurses at a tertiary hospital in Beijing, China. Researchers published their findings online in Frontiers in Neuroscience.
Dizziness and vertigo were...
08/09/2022
Neurology
News
Access to Medical Marijuana Improved Insomnia, but No Change to Pain, Anxiety
06/14/2022
Brionna Mendoza
Patients granted immediate access to medical marijuana exhibited improved self-reported sleep quality and mental well-being, but also displayed higher incidence and severity of cannabis use disorder (CUD), new research says.
Patients granted immediate access to medical marijuana exhibited improved self-reported sleep quality and mental well-being, but also displayed higher incidence and severity of cannabis use disorder (CUD), new research says.
Patients granted immediate...
06/14/2022
Neurology
News
FDA Approves Evoke Spinal Cord Stimulation System for Chronic Intractable Pain
03/25/2022
Jolynn Tumolo
The US Food & Drug Administration recently approved the Evoke® Spinal Cord Stimulation (SCS) System for the treatment of chronic intractable pain of the trunk and/or limbs.
The US Food & Drug Administration recently approved the Evoke® Spinal Cord Stimulation (SCS) System for the treatment of chronic intractable pain of the trunk and/or limbs.
The US Food & Drug...
03/25/2022
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement